Literature DB >> 2897198

Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect.

W Dröge1, H P Eck, H Näher, U Pekar, V Daniel.   

Abstract

The acquired immunodeficiency syndrome (AIDS) is accompanied by a metabolic disturbance. Serum samples from persons with antibodies against the AIDS associated human immunodeficiency virus (HIV/LAV/HTLV III) including persons without overt symptoms, patients with lymphadenopathy syndrome (LAS) and patients with AIDS or AIDS-related complex (ARC) contain on the average significantly elevated concentrations of arginine and glutamate. The serum from patients with overt AIDS contains also, on the average, significantly reduced concentrations of methionine and cystine. In vitro experiments revealed that the [3H]thymidine incorporation by mitogenically stimulated murine lymphocytes and cloned T cells is inhibited by an elevation of the extracellular glutamate concentration and augmented by the addition of cysteine. This suggests the possibility that the abnormal concentrations of glutamate and cystine in the blood of HIV-infected persons may contribute to the defect in the lymphoid system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897198     DOI: 10.1515/bchm3.1988.369.1.143

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.

Authors:  I L Chapple
Journal:  Clin Mol Pathol       Date:  1996-10

2.  Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.

Authors:  H P Eck; P Drings; W Dröge
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Foreword.

Authors:  Klaus Eichmann
Journal:  Immunol Today       Date:  2003-03-19

4.  Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity.

Authors:  V Hack; O Stütz; R Kinscherf; M Schykowski; M Kellerer; E Holm; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

5.  Expression cloning of the cDNA for a polypeptide associated with rat hepatic sinusoidal reduced glutathione transport: characteristics and comparison with the canalicular transporter.

Authors:  J R Yi; S Lu; J Fernández-Checa; N Kaplowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine.

Authors:  R Kinscherf; V Hack; T Fischbach; B Friedmann; C Weiss; L Edler; P Bärtsch; W Dröge
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

7.  Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system.

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

Review 8.  Requirement for prooxidant and antioxidant states in T cell mediated immune responses.--Relevance for the pathogenetic mechanisms of AIDS?

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Klin Wochenschr       Date:  1991-12-15

9.  Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens.

Authors:  M Suthanthiran; M E Anderson; V K Sharma; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs.

Authors:  Gabriel Gojon; Guillermo A Morales
Journal:  Antioxid Redox Signal       Date:  2020-06-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.